Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT03373019 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Chidamide
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Neoplasm by Histology
Neoplasms
Lymphoproliferative Disorders
Lymphatic Diseases
Immunoproliferative Disorders
Immune System Diseases
Lymphoma, Non-Hodgkin
Cyclophosphamide
Rituximab
Gemcitabine
Cisplatin
Dexamethasone
HDAC Inhibitor

Interventions

DRUG: Chidamide combined with R-GDP

Sponsor

Fudan University